Update: Eli Lilly, Novo Nordisk to Cut Obesity Drug Prices Under Deals With Trump Administration

Published 3 days ago • Nov 6, 2025 at 6:35 PM • Neutral

(Updates with additional details in the third to fifth paragraphs.) Eli Lilly (LLY) and Novo Nord

PREMIUM

Upgrade to read this MT Newswires article and get so much more.

A Silver or Gold subscription plan is required to access premium news articles.

Upgrade

Already have a subscription? Sign in

Menu

Update: Eli Lilly, Novo Nordisk to Cut Obesity Drug Prices Under Deals With Trump Administration

Related Stocks

More News

EUR/USD: There are still many clouds ahead of our EUR/USD forecast – Commerzbank

Multi-Tenant Data Centers Business Analysis Report 2025: Market to Reach $91 Billion by 2030, Driven by Growing Demand for Scalable IT Infrastructure and Rise in 5G Deployments

Car-as-a-Service (CaaS) Strategic Business Report 2025: Market to Reach $799.3 Billion by 2030 with Blinkers, BMW, Capital Lease Group, Carly Holdings, and Getaround Driving Expansion

EUR: Rally needs a helping hand – ING

Data Center Maintenance and Support Services Business Report 2025: Market to Reach $28.5 Billion by 2030, Driven by Data Volumes, Uptime Demands, Complex IT Infrastructure, and Regulatory Pressures